HRSA Launches New CARES Act Fund to Cover COVID-19 Testing and Treatment
Provider Reimbursement of Uninsured Testing and Treatment
On April 27, 2020, the Health and Human Services, Health Resources & Services Administration (HRSA) launched a new CARES mandated fund to reimburse health care providers for COVID-19 related testing and treatment.
The HRSA application portal will begin accepting patient information and claims for payment starting May 6.
Reimbursement will be made for qualified COVID-19 testing and treatment with a primary COVID-19 diagnosis, including the following:
- Specimen collection, diagnostic and antibody testing.
- Testing-related visits including in the following settings: office, urgent care or emergency room or via telehealth.
- Treatment, including office visit (including via telehealth), emergency room, inpatient, outpatient/observation, skilled nursing facility, long-term acute care (LTAC), acute inpatient rehab, home health, DME (e.g., oxygen, ventilator), emergency ground ambulance transportation, non-emergent patient transfers via ground ambulance, and FDA-approved drugs as they become available for COVID-19 treatment and administered as part of an inpatient stay.
- FDA-approved vaccine, when available.
- For inpatient claims, date of admittance must be on or after February 4, 2020.
Please review the HRSA FAQs for additional eligibility requirements: https://www.hrsa.gov/coviduninsuredclaim/frequently-asked-questions
Be sure to log-in to the HRSA Portal on May 6 to submit claims: https://coviduninsuredclaim.linkhealth.com/